Lataa...
Cystic Fibrosis Treatment: A Paradigm for New Pediatric Medicines, Globalization of Drug Development and the Role of the European Medicines Agency
The European Pediatric Pharmaceutical Legislation wants children to benefit more from pharmaceutical progress. In rare diseases, concerns have been raised that this legislation might damage research and stymie drug development. We discuss the role of the European Medicines Agency (EMA) and its Pedia...
Tallennettuna:
| Julkaisussa: | Children (Basel) |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4928746/ https://ncbi.nlm.nih.gov/pubmed/27417354 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/children2010108 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|